Li Ning
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Sphingolipid Metabolism and Signaling
- Histone Deacetylase Inhibitors Research
- Developmental Biology and Gene Regulation
- Epigenetics and DNA Methylation
Papers in
-
- Natural product bioactivities and synthesis 6
- Histone Deacetylase Inhibitors Research 2
- RNA modifications and cancer 2
- Cancer-related gene regulation 2
-
- Phytochemistry and Biological Activities 5
- Co-authors
- Herbert Chen (5 shared papers)Muthusamy Kunnimalaiyaan (3 shared papers)David Yü Greenblatt (2 shared papers)Sharon M. Weber (1 shared paper)Bo Wang (1 shared paper)Huiqing Lin (1 shared paper)Peng Xue (1 shared paper)Megan R. Haymart (1 shared paper)
- Journals
- Brazilian Journal of Medical and Biological Research (1 paper)Molecular Cancer Therapeutics (1 paper)Annals of the Rheumatic Diseases (1 paper)OncoTargets and Therapy (1 paper)Clinical Immunology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Li Ning
30 papers receiving 496 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 86
- Molecular Biology 339
- Oncology 106
- Biological Psychiatry 9
- Molecular Medicine 15
Countries citing papers authored by Li Ning
This map shows the geographic impact of Li Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ning more than expected).
Fields of papers citing papers by Li Ning
This network shows the impact of papers produced by Li Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ning. The network helps show where Li Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 74 | |
| 2 | 2008 | 65 | |
| 3 | Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. | 2009 | 62 |
| 4 | 2023 | 49 | |
| 5 | 2008 | 47 | |
| 6 | 2024 | 44 | |
| 7 | 2009 | 41 | |
| 8 | 2007 | 29 | |
| 9 | 2010 | 14 | |
| 10 | 2020 | 12 | |
| 11 | 2018 | 10 | |
| 12 | 2011 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2003 | 7 | |
| 15 | 2014 | 7 | |
| 16 | A New Lignan Glycoside from Curculigo capitulata | 2003 | 6 |
| 17 | 2018 | 4 | |
| 18 | Isolation and identification of pterocarpans and isoflavones from the pericarp of Sphaerophysa salsula DC | 2003 | 3 |
| 19 | 2019 | 3 | |
| 20 | Study of Inappropriate LOS of Patients with Alcoholic Liver Cirrhosis | 2013 | 2 |
About Li Ning
Li Ning is a scholar working on Molecular Biology, Plant Science, Pharmacology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 30 papers that have together received 508 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (6 papers), Phytochemistry and Biological Activities (5 papers), Natural Compounds in Disease Treatment (2 papers), Cell Adhesion Molecules Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), RNA modifications and cancer (2 papers), Cancer-related gene regulation (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (86 citations), Molecular Biology (339 citations), Oncology (106 citations), Biological Psychiatry (9 citations) and Molecular Medicine (15 citations). Li Ning has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Herbert Chen, Muthusamy Kunnimalaiyaan, David Yü Greenblatt, Sharon M. Weber, Bo Wang, Huiqing Lin, Peng Xue, Megan R. Haymart, Min‐Bin Chen and Joel T. Adler. Their work appears in journals such as Brazilian Journal of Medical and Biological Research, Molecular Cancer Therapeutics, Annals of the Rheumatic Diseases, OncoTargets and Therapy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.